Position in CGC
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$66,915
-$17,147 QoQ
Shares Held
70,512
-4.4% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $43,907,952 across 35 Drug Manufacturers - Specialty & Generic names. CGC ranks #28 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
101,839 | $12,038,388 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
300,752 | $6,243,611 | |
| 3 | AQST |
Aquestive Therapeutics, Inc.
|
1,082,680 | $4,493,122 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
146,008 | $4,397,760 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
6,625 | $3,928,492 | |
| 6 | VTRS |
Viatris Inc
|
151,554 | $2,047,494 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
15,356 | $2,022,999 | |
| 8 | HLN |
Haleon plc
|
193,750 | $1,939,437 |
All Filings in CGC
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,915 | 70,512 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $84,062 | 73,739 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $87,490 | 59,925 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $70,403 | 57,708 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $48,632 | 53,442 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $141,564 | 51,666 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $241,901 | 50,187 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $358,400 | 55,566 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $399,914 | 46,340 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $259,475 | 50,778 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||